Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000494187 | SCV000582175 | likely pathogenic | not provided | 2015-09-14 | criteria provided, single submitter | clinical testing | The V481E variant in the ALDH7A1 gene has not been published as a pathogenic variant, nor has it been reported as a benign polymorphism to our knowledge. The V481E variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The V481E variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species and in silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in nearby residues (S476L, D477N, C478S) have been reported in the Human Gene Mutation Database in association with pyridoxine-dependent epilepsy and alpha-AASA dehydrogenase deficiency (Stenson et al., 2014), supporting the functional importance of this region of the protein. The V481E variant is a strong candidate for a disease-causing variant, however the possibility it may be a rare benign variant cannot be excluded. |